KETODEX for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery

Strabismus surgery for children is a very common procedure, with a high incidence of emergence delerium in the recovery room. A combination of intravenous ketamine/dexmedetomidine, or ketodex, has been previously shown to reduce emergence delerium in children undergoing adenotonsillectomy. Here, we study its application in strabismus surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Emergence Delirium Confusion Cranial Nerve Diseases Delirium Eye Diseases Mental Disorders Nervous System Diseases Neurobehavioral Manifestations Neurocognitive Disorders Neurologic Manifestations Ocular Motility Disorders Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications Signs and Symptoms Strabismus

Age range

Up to 18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ochsner Main Campus

Jefferson, Louisiana, 70121, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

ASA I/II children undergoing outpatient strabismus surgery

Exclusion criteria

anything not meeting the above

Treatment and study plan

Dexmedetomidine

Drug

see descriptions

Other names: ketamine

Primary outcomes

Pediatric Anesthesia Emergence Delirium scale scores

Time frame: up to 6 hours in recovery room

A low total score would indicate less emergence delirium

Secondary outcomes

wong-baker or numeric pain scores, depending on age

Time frame: up to 6 hours in recovery room

A low total score would indicate less pain
discharge time

Time frame: up to 24 hours

time the patient is actually discharged from recovery room

Sponsors and collaborators

Lead sponsor

Ochsner Health System

Other

Registry information

Important dates

Study start: 2018
Primary completion: 2018
Study completion: 2018
First posted: Dec 19, 2018
Registry last updated: Dec 19, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed